Inclusion, SocialNCT05871450

Legacy of the Special Olympics World Games Berlin 2023

A study testing Inclusive events in people with Inclusion, Social, run by German University of Health and Sports at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Who is it for?: Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for: Inclusion, Social
What is being tested?: Inclusive events
Type of treatment: Lifestyle or therapy programme
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 700 participants
Where: 1 siteGermany
Study dates: 1 Mar 2023to 30 Jun 2024
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
Healthy volunteers accepted
Adult, Older adult

Who may be able to join

legal age

Who cannot join

none

Trial locations and contacts

1 site in 1 country.

Germany1 site

German University of Health and Sport
Berlin, 10587

Other trials in Germany

About this study

This research aims to evaluate the impact of the project "170 Nations - 170 Inclusive Communities" of the Special Olympics World Games 2023 (SOWG 23) on sustain inclusive structures for people with intellectual disabilities (ID). The research utilizes a quasi-experimental research design and a qualitative research design and will synthesize qualitative and quantitative data to display successful and non-successful interventions for more inclusive communities. The research will target 56 host communities of SOWG 23 and 56 non-host communities, interviewing 200 people with ID and a minimum of 400 key stakeholders, as well as conducting qualitative interviews and focus groups.

Conditions: Inclusion, Social
Being tested: Inclusive events
Medical subject headings: Social Inclusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Inclusive eventsBehavioural
Inclusive events such as inclusive sport festivals, citizen festivals or working groups at school are organized

Study groups in NCT05871450
Study group	Role	What they receive
Participants living in Host Towns	Experimental	Participants live in Host Towns, where a delegation of athletes are hosted for one week. Furthermore, Host Town coordinator organize several inclusive events. Receives: Behavioral: Inclusive events
Participants not living in Host Towns	No intervention	Participants where no delegeation of athletes are hosted and no inclusive events are organized by Host Town coordinator.

What is being measured

The primary outcome is the main question the study is designed to answer.

Attitudes Measured With the ATTID-Questionnaire
The ATTID-SF Questionnaire encompassing three core components. The affective component refers to emotional responses toward individuals with intellectual disabilities. The cognitive component encompasses beliefs, knowledge, and perceptions about this population. The behavioral component reflects self-reported actions. The short form comprises 35 items rated on a 5-point Likert scale (1 = strongly agree to 5 = strongly disagree), with higher scores indicating more negative attitudes. Items are grouped into five factors: (1) interaction, (2) sensitivity/tenderness, (3) discomfort, (4) knowledge about abilities, and (5) knowledge about causes of intellectual disabilities. Mean scores are calculated for each factor; however, due to the scale's factor structure, an overall score is not recommended. So the minimum mean score for each factor is 1, the maximum means score is 5.
Measured: Change from baseline (T1) attitudes toward people with intellectual disability (ATTID-Questionnaire) at 3-4 month (T2) and 8-9 month (T3)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1 Mar 202330 Jun 2024

First posted23 May 2023
Study start1 Mar 2023
Primary completion31 Dec 2023
Study completion30 Jun 2024

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Other trials for Inclusion, SocialStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Health services research
Allocation: Randomised
Intervention model: Parallel groups
Masking: None (open label)
Enrolment: 700 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT05871450
Sponsor's protocol ID: SOWG Studie
Status last verified: Aug 2025
First submitted: 4 May 2023
Last updated: 28 Aug 2025
Results posted: Yes, on ClinicalTrials.gov
FDA-regulated drug: No
FDA-regulated device: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Not yet recruitingPhase 2
An Investigation of Mechanisms That Underly Paranoia in Behaviour and Brain That Can Inform Clinical Diagnoses That Include Paranoid Symptoms.
None Volunteer
Enrolling by invitationObservational study
Health, Functioning, Work, and Experiences of Social and Health Services of Persons With Stroke
Stroke, Health, Subjective
Recruiting
The ALIVE-Project: Activity, Life Satisfaction, Inclusion, Vitality, Elderly Women
Loneliness, Social Isolation in Older Adults
Not yet recruiting
Promoting Psychophysical Well-being in Children and Adolescents With Visual Impairment
Visual Impairment, Cerebral Visual Impairment
RecruitingObservational study
The Effect of Comorbid Alcohol/Substance Use
Alcohol Abuse, Alcohol Use Disorder

All Inclusion, Social trials

Study at a glance

From the registry record, last updated by the sponsor on 28 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Legacy of the Special Olympics World Games Berlin 2023
ClinicalTrials.gov ID: NCT05871450
Acronym / sponsor ID: SOWG Studie
Conditions: Inclusion, Social
Study type: Interventional
Recruitment status: Completed
Enrolment: 700 participants (actual)
Lead sponsor: German University of Health and SportsUniversity, hospital or other
Study start: 1 Mar 2023 (actual)
Primary completion: 31 Dec 2023 (actual)
Study completion: 30 Jun 2024 (actual)
First posted: 23 May 2023 (actual)
Results: Posted 28 Aug 2025

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Primary purpose: Health services research
Allocation: Randomised
Intervention model: Parallel groups
Masking: None (open label)
Number of arms: 2

Arm	Type	Receives
Participants living in Host Towns	Experimental	Behavioral: Inclusive eventsParticipants live in Host Towns, where a delegation of athletes are hosted for one week. Furthermore, Host Town coordinator organize several inclusive events.
Participants not living in Host Towns	No intervention	–Participants where no delegeation of athletes are hosted and no inclusive events are organized by Host Town coordinator.

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Accepted
Age groups: Adult, Older adult

Key inclusion criteria (1 listed)

legal age

Key exclusion criteria (1 listed)

none

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Inclusive eventsInclusive events such as inclusive sport festivals, citizen festivals or working groups at school are organized	Behavioural	Participants living in Host Towns

Primary outcome

Attitudes Measured With the ATTID-Questionnaire
Time frame: Change from baseline (T1) attitudes toward people with intellectual disability (ATTID-Questionnaire) at 3-4 month (T2) and 8-9 month (T3)
The ATTID-SF Questionnaire encompassing three core components. The affective component refers to emotional responses toward individuals with intellectual disabilities. The cognitive component encompasses beliefs, knowledge, and perceptions about this population. The behavioral component reflects self-reported actions. The short form comprises 35 items rated on a 5-point Likert scale (1 = strongly agree to 5 = strongly disagree), with higher scores indicating more negative attitudes. Items are grouped into five factors: (1) interaction, (2) sensitivity/tenderness, (3) discomfort, (4) knowledge about abilities, and (5) knowledge about causes of intellectual disabilities. Mean scores are calculated for each factor; however, due to the scale's factor structure, an overall score is not recommended. So the minimum mean score for each factor is 1, the maximum means score is 5.

Results and safety

Results posted to the registry on 28 Aug 2025, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
Participants Living in Host Towns	342	183
Participants Not Living in Host Towns	146	70

Primary outcome: Attitudes Measured With the ATTID-Questionnaire

Time frame: Change from baseline (T1) attitudes toward people with intellectual disability (ATTID-Questionnaire) at 3-4 month (T2) and 8-9 month (T3). Mean (Standard Deviation). Unit: mean change score

Measure	Participants Living in Host Towns n = 342	Participants Not Living in Host Towns n = 146
T1 Discomfort	1.95 (0.77)	2.20 (0.76)
T1 Knowledge of capacity and rights	1.78 (0.55)	2.04 (0.55)
T1 Interaction	2.22 (0.65)	2.41 (0.71)
T1 Sensitivity or tenderness	2.57 (0.95)	2.71 (0.94)
T1 Knowledge of causes	1.89 (0.55)	2.07 (0.42)
T2 Discomfort	1.92 (0.81)	2.19 (0.76)
T2 Knowledge of capacity and rights	1.82 (0.51)	1.99 (0.50)
T2 Interaction	2.21 (0.63)	2.45 (0.64)

Participants Living in Host Towns vs Participants Not Living in Host Towns: p = 0.05, Regression, Linear

Population analysed: The difference is due to dropouts during the follow-up assessment

Adverse events

Time frame: Adverse events were not monitored. Other adverse events reported at 0% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
Participants Living in Host Towns	0 of 0	0 of 0	0
Participants Not Living in Host Towns	0 of 0	0 of 0	0

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 28 Aug 2025.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.

Related trials for Inclusion, Social

Not yet recruitingPhase 2
An Investigation of Mechanisms That Underly Paranoia in Behaviour and Brain That Can Inform Clinical Diagnoses That Include Paranoid Symptoms.
None Volunteer
Enrolling by invitationObservational study
Health, Functioning, Work, and Experiences of Social and Health Services of Persons With Stroke
Stroke, Health, Subjective
Recruiting
The ALIVE-Project: Activity, Life Satisfaction, Inclusion, Vitality, Elderly Women
Loneliness, Social Isolation in Older Adults
Not yet recruiting
Promoting Psychophysical Well-being in Children and Adolescents With Visual Impairment
Visual Impairment, Cerebral Visual Impairment
RecruitingObservational study
The Effect of Comorbid Alcohol/Substance Use
Alcohol Abuse, Alcohol Use Disorder

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Wolfgang Ruf, PhD study chair

German University of Health and Sports

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Inclusive events in people with Inclusion, Social, run by German University of Health and Sports at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 28 Aug 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attitudes Measured With the ATTID-Questionnaire (time frame: Change from baseline (T1) attitudes toward people with intellectual disability (ATTID-Questionnaire) at 3-4 month (T2) and 8-9 month (T3)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05871450.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2025.